Single-Agent Liposomal All-Trans-Retinoic Acid as Initial Therapy for Acute Promyelocytic Leukemia: 13-Year Follow-Up Data
Open accessThe claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The advantages of RA formulations have been demonstrated in preclinical (in all applications described in this review) and clinical trials (cancer and skin applications).
“The advantages of RA formulations have been demonstrated in preclinical (in all applications described in this review) and clinical trials (cancer and skin applications)71,129.”
From Advances and challenges in retinoid delivery systems in regenerative and therapeutic medicine (2020) · cites this paper as [129]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Shen, Z., Shi, Z., Fang, J., Gu, B.-W., Li, J., Zhu, Y., Shi, J., Zheng, P., Yan, H., Liu, Y., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400053101 · Cited by 583 · see citing works
Ravandi, F., Estey, E., Jones, D. M., Faderl, S. H., O'Brien, S. M., Fiorentino, J., Pierce, S. A., Blamble, D., Estrov, Z. E., Wierda, W. G., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.6130 · Cited by 376 · see citing works
Self-citationMathews, V., George, B., Chendamarai, E., Lakshmi, K. M., Desire, S., Balasubramanian, P., Viswabandya, A., Rajashekar, T., Abraham, A., Velayudhan, S. R., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.5031 · Cited by 250 · see citing works
Treatment of newly diagnosed acute promyelocytic leukemia without cytarabine.
Estey, E., Thall, P. F., Pierce, S., Kantarjian, H., & Keating, M. J. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.2.483 · Cited by 125 · see citing works
Self-citationEstey, E. H., Giles, F. J., Kantarjian, H., O’Brien, S., Cortes, J., Freireich, E. J., Lopez-Berestein, G., & Keating, M. (1999) · Blood · doi:10.1182/blood.v94.7.2230.419k05_2230_2235 · Cited by 105 · see citing works
Self-citationHow to manage acute promyelocytic leukemia
Mi, J.-Q., Li, J., Shen, Z.-X., Chen, S.-J., & Chen, Z. (2012) · Leukemia · doi:10.1038/leu.2012.57 · Cited by 97 · see citing works
Özpolat, B., Lopez‐Berestein, G., Adamson, P. C., Fu, C. J., & Williams, A. H. (2003) · PubMed · Cited by 81 · see citing works
Self-citationTsimberidou, A. M., Tírado-Gómez, M., Andreeff, M., O'Brien, S. M., Kantarjian, H. M., Keating, M. J., Lopez‐Berestein, G., & Estey, E. H. (2006) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190500463932 · Cited by 58 · see citing works
Self-citationAcute promyelocytic leukemia can be treated successfully without cytotoxic chemotherapy.
Ravandi, F. (2011) · PubMed · Cited by 6 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Wei, S., Kozono, S., Kats, L., Nechama, M., Li, W., Guarnerio, J., Luo, M., You, M.-H., Yao, Y., Kondo, A., et al. (2015) · Nature Medicine · doi:10.1038/nm.3839 · Cited by 272 · see citing works
The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target
Zhou, X. Z., & Lu, K. P. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.49 · Cited by 269 · see citing works
Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy
Koikawa, K., Kibe, S., Suizu, F., Sekino, N., Kim, N., Manz, T. D., Pinch, B. J., Akshinthala, D., Verma, A., Gaglia, G., et al. (2021) · Cell · doi:10.1016/j.cell.2021.07.020 · Cited by 235 · see citing works
Advances and challenges in retinoid delivery systems in regenerative and therapeutic medicine
Ferreira, R., Napoli, J., Enver, T., Bernardino, L., & Ferreira, L. (2020) · Nature Communications · doi:10.1038/s41467-020-18042-2 · Cited by 138 · see citing works
Nanotechnology Toward Treating Cancer
Pillai, G. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814029-1.00009-0 · Cited by 57 · see citing works
Lian, X., Lin, Y., Kozono, S., Herbert, M. K., Li, X., Yuan, X., Guo, J., Guo, Y., Tang, M., Lin, J. L., et al. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0611-7 · Cited by 33 · see citing works
Grace, V. M. B., & Viswanathan, S. (2017) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2017.04.005 · Cited by 32 · see citing works
Cull, E. H., & Altman, J. K. (2014) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-014-0205-6 · Cited by 31 · see citing works
Makinwa, Y., Musich, P. R., & Zou, Y. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00281 · Cited by 22 · see citing works
Novel Cellular Functions of ATR for Therapeutic Targeting: Embryogenesis to Tumorigenesis
Biswas, H., Makinwa, Y., & Zou, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411684 · Cited by 13 · see citing works
Lu, K. P., & Zhou, X. Z. (2024) · Science Signaling · doi:10.1126/scisignal.adi8743 · Cited by 11 · see citing works
Tallman, M. S. (2014) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2014.04.010 · Cited by 4 · see citing works
Bai, D., Zhang, Z., Gao, J., Wang, Q., Macdonald, R., Xu, Z., Chen, S., Huang, N., & Luo, L. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1619352 · Cited by 1 · see citing works
Wiernik, P. H., Gallagher, R. E., & Tallman, M. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-64263-5_21 · Cited by 1 · see citing works
Daniyal, M., Polani, A., Kumar, A., Raja, A., & Canary, M. (2025) · Cureus · doi:10.7759/cureus.84943
- Authors
- Jain, P., Kantarjian, H., Estey, E., Pierce, S., Cortes, J., Lopez-Berestein, G., & Ravandi, F.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Fred Hutch Cancer Center (US)
- Venue
- Clinical Lymphoma Myeloma and Leukemia
- Publisher
- Elsevier BV
- Published
- 2014-02
- Volume
- 14
- Issue
- 1
- Pages
- e47-e49
- ISSN
- 2152-2650 (ISSN-L)
- PMC
- PMC4103408
- OpenAlex
- W2156213129
- Cited by
- 15
- References
- 9
- Citations by year
- 2025: 2 · 2024: 1 · 2023: 1 · 2021: 1 · 2020: 2 · 2018: 2 · 2017: 2 · 2016: 1 · 2015: 1 · 2014: 2
- FWCI
- 0.60
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Lymphoma Myeloma & Leukemia (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (P30CA016672)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Health Sciences › Medicine › Dermatology › Acne and Rosacea Treatments and Effects
- Keywords
- acute promyelocytic leukemia, all-trans retinoic acid, liposomal drug delivery, monotherapy, first-line therapy, long-term follow-up, pharmacokinetics
- MeSH terms
- Adolescent, Adult, Aged, Child, Follow-Up Studies, Humans, Liposomes, Middle Aged, Remission Induction, Tretinoin, Leukemia, Promyelocytic, Acute, Disease-Free Survival, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
